Healthcare DIVE June 13, 2019
Dive Brief:
- IBM, Walmart, KPMG and Merck & Co. said the U.S. Food and Drug Administration chose them to be part of a blockchain pilot program designed to track and ensure the integrity of prescription medicines and vaccines.
- The companies said they expect to complete the program in the fourth quarter of this year, with results slated for publication in an FDA report.
- Participants “will evaluate next steps” after the conclusion of the pilot, the companies said in a joint statement Thursday.
The four industry powerhouses are the latest to tackle the need for an interoperable system that can track and trace medications across the supply...